Table 2.
Antibiotic consumption by children in the community in Greece per clinical indication.
| Clinical indication/Antibiotic* | n (%) N = 465 |
|---|---|
| Acute otitis media (n = 127) | |
| Amoxicillin | 41 (32.3) |
| Amoxicillin/clavulanate | 38 (29.9) |
| 2nd generation cephalosporin | 28 (22.1) |
| Clarithromycin | 9 (7.1) |
| Unknown | 11 (8.7) |
| Pharyngotonsillitis (n = 118) | |
| Amoxicillin/clavulanate | 6 (30.5) |
| Amoxicillin | 32 (27.1) |
| Clarithromycin or azithromycin | 27 (22.9) |
| 2nd generation cephalosporin | 14 (11.9) |
| Unknown | 9 (7.6) |
| Bronchitis (n = 83) | |
| Clarithromycin | 23 (27.7) |
| 2nd generation cephalosporin | 17 (20.5) |
| Amoxycillin/clavulanate | 15 (18.1) |
| Azithromycin | 5 (6.0) |
| Amoxycillin | 4 (4.8) |
| Unknown | 19 (22.9) |
| Urinary tract infection (n = 14) | |
| Amoxicillin/clavulanate | 5 (35.7) |
| Cefuroxime | 4 (28.6) |
| Cefaclor | 1 (28.6) |
| Amoxycillin | 1 (7.1) |
| Unknown | 3 (21.4) |
| Pneumonia (n = 11) | |
| Amoxicillin | 4 (36.4) |
| Amoxicillin/clavulanate | 2 (18.2) |
| Clarithromycin | 2 (18.2) |
| Cefuroxime | 1 (9.1) |
| Unknown | 2 (18.2) |
| Skin infection (n = 11) | |
| Amoxicillin/clavulanate | 4 (36.4) |
| Clarithromyicin | 3 (27.3) |
| 2nd generation cephalosporin | 1 (9.1) |
| Unknown | 3 (27.3) |
* Clinical indications with at least 10 antibiotic courses are presented.